Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Hyperosmolar hyperglycaemic state (HHS) as the first manifestationof type 2 diabetes in a child
Agnieszka Zubkiewicz-Kucharska1, Joanna Chrzanowska1, Anna Noczyńska1
1Department of Endocrinology and Diabetology for Children and Adolescents, Wrocław Medical University, Poland.
Insights
Hyperglycaemic hyperosmolar state (HHS) can affect young individuals with diabetes. This case highlights HHS in an obese adolescent with type 2 diabetes, complicated by pneumonia and requiring significant weight loss and respiratory support.
Area of Science:
- Endocrinology
- Pediatrics
- Metabolic Disorders
Background:
- Hyperglycaemic hyperosmolar state (HHS) is a serious diabetic emergency characterized by extreme hyperglycemia and dehydration.
- While often seen in adults, HHS can occur in younger populations with type 1 and type 2 diabetes, and even in infants.
Observation:
- A 13-year-old obese patient (BMI > 40 kg/m²) presented with severe HHS (glucose 647 mg/dl, osmolarity 370 mOsm/kg) during pneumonia.
- The patient had newly diagnosed type 2 diabetes (HbA1c 15.5%) with preserved C-peptide levels (2.63 ng/ml).
- Initial management involved insulin, followed by metformin, dietary changes, and rehabilitation, leading to substantial weight reduction (37 kg in 6 months).
Findings:
- The case illustrates HHS development in a severely obese adolescent with type 2 diabetes, triggered by an acute illness (pneumonia).
- Effective management included pharmacotherapy adjustments (discontinuation of insulin, initiation of metformin), lifestyle interventions, and rehabilitation.
- Despite significant clinical improvement and weight loss, the patient required ongoing respiratory support (CPAP) for nocturnal breathing disorders.
Implications:
- This case underscores the importance of recognizing HHS in pediatric patients, particularly those with obesity and type 2 diabetes.
- Aggressive management of hyperglycemia, dehydration, and underlying triggers like infection is crucial for favorable outcomes.
- Long-term strategies involving weight management and multidisciplinary care are essential for preventing recurrence and managing comorbidities in this population.
Abstract:
Hyperglycaemic hyperosmolar state (HHS) may occur in young patients with type 1 and type 2 diabetes and in infants with hyperglycaemia. Hyperglycaemic hyperosmolar state is characterised by extremely high glucose concentration, which, by increasing osmotic diuresis, intensifies dehydration. Hyperglycaemic hyperosmolar state criteria include the following: plasma glucose > 600 mg/dl, venous pH > 7.25, sodium bicarbonate > 15 mmol/l, slight ketonuria, plasma osmolality > 320 mOsm/kg, and impairment of consciousness (aggression, unconsciousness, convulsions). We describe the case of a 13-year-old patient with severe obesity (at presentation body mass > 120 kg, BMI > 40 kg/m2), who developed HHS (glycaemia 647 mg/dl, pH 7.18, pCO2 96.5 mmHg, BE - 5.0 mmol/l, HCO3 35.2 mmol/l; Na 167 mmol/l, plasma osmolarity 370 mOsm/kg) in the course of pneumonia and newly diagnosed type 2 diabetes (HbA1c 15.5%, C-peptide 2.63 ng/ml). In the follow-up, due to the hypoglycaemia, insulin was discontinued, metformin was administered at a dose of 2 g/day, with a further reduction to 500 mg/day, together with physical rehabilitation and a low-calorie diet. Weight reduction during 6 months of observation was approximately 37 kg. Due to breathing disorders occurring at night, the girl still needs breathing assistance (CPAP).
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Acute Pancreatitis II: Clinical Manifestations and Management
Angina III: Clinical Manifestations and Assessment
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

